Keyphrases
Preeclampsia
75%
Adverse Perinatal Outcomes
73%
Breast Cancer
70%
Fetus
69%
Breast Cancer Susceptibility Gene 1 (BRCA1)
67%
Cerebroplacental Ratio
63%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
61%
Small-for-gestational Age
53%
Perinatal Outcome
52%
Congenital Heart Disease
49%
Bariatric Surgery
49%
Genetic Testing
49%
BRCA2
45%
Pregnant Women
42%
Germany
41%
Early Cancer Detection
41%
Breast
41%
Late-onset
39%
Hormone Replacement Therapy
37%
Pregnancy Outcome
36%
Breast Cancer Risk
35%
Maternal-fetal
32%
Ovarian Cancer
32%
Fetal Outcome
32%
Placental Growth Factor (PlGF)
31%
During Pregnancy
30%
Non-associated
30%
Operative Delivery
28%
Intrapartum Fetal Compromise
28%
Detection Program
27%
BRCA1, BRCA2
27%
Fetal Growth Restriction
27%
Genetic Counseling
26%
Polymorphism
26%
Obesity
25%
Maternal Infection
25%
Hereditary Breast Cancer
24%
Hereditary Ovarian Cancer
24%
Prospective Cohort Study
24%
Ovarian Steroid Hormones
24%
Chronic Kidney Disease
24%
Japan
24%
Intrapartum
24%
Antiestrogen
24%
Chemoprevention
24%
Hungary
24%
Common Polymorphism
24%
Prolonged Pregnancy
24%
Psychological Support
24%
Myasthenia Gravis
24%
Medicine and Dentistry
Breast Cancer
100%
Pre-Eclampsia
76%
Diseases
63%
Protein Tyrosine Kinase
61%
Intrapartum
61%
Small for Gestational Age
53%
Neoplasm
51%
Bariatric Surgery
49%
Persistent Truncus Arteriosus
49%
Fetus Growth
45%
BRCA1
45%
Ovarian Cancer
43%
Gynecology
40%
Obstetrics
39%
Genetic Screening
37%
Prospective Cohort Study
37%
Instrumental Delivery
36%
Gestational Age
35%
BRCA2
35%
Cesarean Section
32%
Uterine Artery
31%
Early Cancer Detection
30%
Cancer
30%
Premature Labor
30%
Pulsatility Index
27%
Cardiotocography
26%
Maternal Disease
25%
Chronic Kidney Disease
24%
Myasthenia gravis
24%
Congenital Heart Defect
24%
Twin Pregnancy
24%
Hormone Substitution
24%
Antiestrogen
24%
Endometrium
24%
Steroid Hormone
24%
COVID-19
24%
Gestational Diabetes
24%
Counseling
24%
Genetic Counseling
22%
Malignant Neoplasm
19%
Placental Growth Factor
19%
Tamoxifen
19%
Birth Weight
18%
Neonatal Infant
18%
HELLP Syndrome
17%
Neonate
17%
Spontaneous Abortion
17%
Cancer Risk
16%
Cancer Syndrome
16%
Breast Carcinoma
16%